display
London (AP) - The British Vaccination Commission has changed its recommendation for the Astrazeneca vaccine after a review.
In the future, the preparation should only be administered to adults over the age of 30 if possible, as the commission announced.
This is due to reports of rare cases of blood clots in connection with vaccination with the vaccine.
In Great Britain, 79 cases of rare blood clots have so far occurred after vaccination with the Astrazeneca vaccine, according to the MHRA.
There were 19 deaths.
Most of these cases involved young people.
According to the vaccination commission, a direct connection with the vaccine has not yet been proven.
But in view of the lower risk of younger people dying of Covid-19, this consideration has been made, it said.
display
In Germany, the federal and state health ministers had decided, because of the thrombosis cases that mainly occurred in young women, to generally only administer the preparation to people aged 60 and over.
For younger people, vaccination is only possible after they have been informed about the risks at their own risk.
The vaccine is only recommended to a limited extent in other countries.
In France, for example, it is only given to people over the age of 55.
The EU Medicines Agency EMA had previously announced that it would not restrict the use of Astrazeneca's corona vaccine despite the rare occurrence of blood clots.
According to the authority, the benefits of the active ingredient should be rated higher than the risks.
Oxford University had temporarily stopped a clinical trial of the Astrazeneca vaccine in children and adolescents because of the review.
© dpa-infocom, dpa: 210407-99-116493 / 7